Study on Traditional Chinese Medicine for Treating COVID-19
Pages 184 - 188
Abstract
COVID-19, new coronavirus pneumonia, refers to viral pneumonia caused by new coronavirus (named as 2019-nCoV), with fever, cough, headache, fatigue, difficulty breathing and other symptoms as the main clinical manifestations. The earliest COVID-19 patients in our country were found in Wuhan. The virus is highly infectious and the infection is usually in 14 days from infection to onset. The clinical characteristics of COVID-19 infection is complex and can be roughly classified into mild, moderate, severe and critically ill patients. To get the infection controlled, China has carried out the combination therapy of Chinese and western medicine. In the aspect of traditional Chinese medicine (TCM) therapy, the body has been regarded as a organic whole. In different cases or stages, TCM therapy has been modified according to the details of patients. TCM therapy emphasizes the balance of vital qi and pathogenic factors. In this review, we discussed the effective Chinese medicines included in "New Coronavirus Pneumonia Diagnosis and Treatment Program" and potential mechanisms of TCM therapy when treating COVID-19.
References
[1]
Li, Q., Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.N Engl J Med, 2020. 382 (13): p. 1199-1207.
[2]
Wang, C., A novel coronavirus outbreak of global health concern.Lancet, 2020. 395 (10223): p. 470-473.
[3]
World Health Organization. Coronavirus disease (COVID-19) outbreak Geneva: World Health Organization; 2020.
[4]
Ang, L., Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines.Integr Med Res, 2020. 9 (2): p. 100407.
[5]
Ho, L.T.F., Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19.Eur J Integr Med, 2020: p. 101116.
[6]
Shereen, M.A., COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.J Adv Res, 2020.24: p. 91-98.
[7]
Wu, J.T., K. Leung, and G.M. Leung, Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.Lancet, 2020. 395 (10225): p. 689-697.
[8]
Xie, P., Severe COVID-19: A Review of Recent Progress With a Look Toward the Future.Front Public Health, 2020.8: p. 189.
[9]
Zou, X., Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.Front Med, 2020. 14 (2): p. 185-192.
[10]
Lu, R., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.Lancet, 2020. 395 (10224): p. 565-574.
[11]
Li, T., H. Lu, and W. Zhang, Clinical observation and management of COVID-19 patients.Emerg Microbes Infect, 2020. 9 (1): p. 687-690.
[12]
National Administration of Traditional Chinese Medicine. Notice on the promulgation of the National COVID-19 Diagnostic and Treatment Guideline (Provisional Version 7) (Chinese).
[13]
Liu, J., Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis.J Altern Complement Med, 2004. 10 (6): p. 1041-51.
[14]
Wang, X. and Z. Liu, Prevention and treatment of viral respiratory infections by traditional Chinese herbs.Chin Med J (Engl), 2014. 127 (7): p. 1344-50.
[15]
Hsieh, C.F., Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.J Ethnopharmacol, 2012. 143 (1): p. 57-67.
[16]
Ding, Y., The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function.BMC Complement Altern Med, 2017. 17 (1): p. 130.
[17]
Yang, X.L., [Study on in vitro anti-inflammatory activity of total flavonoids from Glycyrrhizae Radix et Rhizoma and its ingredients].Zhongguo Zhong Yao Za Zhi, 2013. 38 (1): p. 99-104.
[18]
Lu, H.M., Anti-inflammatory effect of Houttuynia cordata injection.J Ethnopharmacol, 2006. 104 (1-2): p. 245-9.
[19]
Dong, L., Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease.Evid Based Complement Alternat Med, 2014.2014: p. 637969.
[20]
Luo, H., Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.Chin J Integr Med, 2020. 26 (4): p. 243-250.
Recommendations
Interactions between traditional Chinese medicine and western drugs in Taiwan
Most commonly interacting Chinese herbs were Ephedrae Herba and Angelicae Sinensis Radix/Angelicae Dahuricae Radix.Unique cultural factors that have resulted in widespread acceptance of both western and traditional Chinese medicine.Taiwan stands well ...
Rule-Based text mining of chinese herbal medicines with patterns in traditional chinese medicine for chronic obstructive pulmonary disease
WISM'12: Proceedings of the 2012 international conference on Web Information Systems and MiningThrough several thousands years of clinical research and theoretical thoughts, traditional Chinese medicine (TCM) has accumulated rich experiences on Chronic Obstructive Pulmonary Disease (COPD). However, the usage of Chinese herbal medicines in ...
Assessment of the potential value of combining western medicine therapies with traditional chinese medicine in the treatment of COVID-19: Mechanistic perspectives
BACKGROUND:The pandemic caused by the novel coronavirus disease (COVID-19) since early 2020 is one of the most significant global health issues in history. Although there is currently no specific treatment for COVID-19, ...
Comments
Information & Contributors
Information
Published In
November 2020
197 pages
ISBN:9781450388221
DOI:10.1145/3444884
Copyright © 2020 ACM.
Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected].
Publisher
Association for Computing Machinery
New York, NY, United States
Publication History
Published: 31 March 2021
Check for updates
Author Tags
Qualifiers
- Research-article
- Research
- Refereed limited
Conference
ICBBE '20
ICBBE '20: 2020 7th International Conference on Biomedical and Bioinformatics Engineering
November 6 - 9, 2020
Kyoto, Japan
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 42Total Downloads
- Downloads (Last 12 months)1
- Downloads (Last 6 weeks)0
Reflects downloads up to 08 Feb 2025
Other Metrics
Citations
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign inFull Access
View options
View or Download as a PDF file.
PDFeReader
View online with eReader.
eReaderHTML Format
View this article in HTML Format.
HTML Format